123572-64-5

Basic information

• Product Name: 2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene
• Synonyms: 2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene
• CAS NO: 123572-64-5
• Molecular Formula: C₇H₃F₄NO₃
• Molecular Weight: 225.0972328
• Mol File: 123572-64-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene(123572-64-5)
• EPA Substance Registry System: 2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene(123572-64-5)

Safety Data

• Hazardous Substances Data: 123572-64-5(Hazardous Substances Data)

Usage

General Description

2-Fluoro-1-nitro-4-(trifluoromethoxy)benzene is a chemical compound with the molecular formula C7H4F4NO3. It is a fluoro-substituted nitrobenzene derivative that is often used as a building block in the synthesis of pharmaceuticals and agrochemicals. It is also used as a reagent for organic synthesis and in research. The chemical is a yellow solid with a molecular weight of 207.1 g/mol. It is important to handle this chemical with care, as it is a hazardous substance that can cause skin and eye irritation upon contact.

Upstream product

• 1077-01-6 meta-fluoro(trifluoromethoxy)benzene 

Downstream Products

• 1159795-41-1 4-methyl-1-(2-nitro-5-trifluoromethoxy-phenyl)-1H-imidazole 
• 168971-68-4 1-bromo-2-fluoro-4-(trifluoromethoxy)benzene 
• 123572-58-7 2-fluoro-4-(trifluoromethoxy)aniline 

Relevant articles and documents

6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

A 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and medical use thereof, in particular, a 6-oxo-1,6-dihydropyridazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, and use thereof as a NaV inhibitor and use thereof in the preparation of a drug for the treatment and/or prevention of pain and pain-related diseases. Each substituent in general formula (I) is the same as defined in the description.

ARYL AND HETEROARYL FUSED IMIDAZO[1,5-a]PYRAZINES AS INHIBITORS OF PHOSPHODIESTERASE 10

The invention relates to imidazo[1,5-a]pyrazine derivatives, to processes for preparing them, to pharmaceutical preparations which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10 (PDE10), as active compounds for treating central nervous system diseases of mammals, including humans.